New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...

Biomea Fusion (BMEA) announced the presentation of new preclinical and clinical data for icovamenib, the company’s ...

Zhejiang University School of Medicine in China, along with American researchers, has found no link between late-life intake ...

In a rodent model of type 2 diabetes (T2D), icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and b ...

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce the successful de ...

CagriSema is a once-weekly injection of semaglutide and cagrilintide. Clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a ...

A breakthrough clinical trial in Japan reveals that a vitamin B3 derivative significantly improves symptoms of the rare ...

GRAND RAPIDS, MI, USA I June 20, 2025 I Cirius Therapeutics, Inc., a developer of innovative therapies for patients suffering from diseases caused by ...

GoPath Diagnostics, a leading provider of molecular and digital pathology services, today announced the launch of DiabetesNow ...

A new study has found a link between certain midlife vascular risk factors — specifically high blood pressure, diabetes, and ...

Diabetes is increasing due to obesity and lack of exercise, and if type 2 diabetes patients are accompanied by mental illness ...

Head of the Metabolic Neuroscience Laboratory, investigates the brain ‘goo’ behind obesity and Type-2 diabetes - and how we ...